Literature DB >> 18037741

Activity monitoring in heart failure patients with cardiac resynchronization therapy.

Mihoko Kawabata1, Cecilia Fantoni, Francois Regoli, Santi Raffa, Francesca Pastori, Simona Fratini, John Prentice, Helmut U Klein, Angelo Auricchio.   

Abstract

BACKGROUND: Cardiac resynchronization therapy (CRT) improves functional capacity in heart failure patients. This study aimed to prospectively analyze long-term device-based monitoring of physical activity in patients undergoing CRT. METHODS AND
RESULTS: The Activity Log Index (ALI), calculated by CRT devices, represents the percentage of time when acceleration exceeds a threshold and monitors the physical activity. Data from 178 CRT patients (New York Heart Association III 91%, left ventricular ejection fraction 21+/-6%, left ventricular end-diastolic diameter 69+/-9 mm, QRS 159+/-27 ms, sinus rhythm 81%) were retrieved. The ALI increased from a baseline value of 3.6+/-2.0 to 11.2+/-4.6 (p<0.005) 104 weeks after initiation of CRT. A plateau was reached at approximately 12 weeks and thereafter ALI remained stable for up to 2 years. The magnitude of the changes in ALI was similar in patients with different etiologies and underlying rhythms. Despite similar values at baseline, elderly patients (>or=65 years) exhibited significantly lower ALI values than younger patients during the follow-up and at the plateau (9.5+/-4.2 vs 13.3+/-4.8, p<0.001).
CONCLUSIONS: Device-based monitoring of physical activity in CRT patients is feasible. CRT resulted in a large and long-term increase in physical activity.

Entities:  

Mesh:

Year:  2007        PMID: 18037741     DOI: 10.1253/circj.71.1885

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

1.  Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices.

Authors:  David Snipelisky; Jacob Kelly; James A Levine; Gabriel A Koepp; Kevin J Anstrom; Steven E McNulty; Rosita Zakeri; G Michael Felker; Adrian F Hernandez; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2017-06       Impact factor: 8.790

Review 2.  Nitrate's effect on activity tolerance in heart failure with preserved ejection fraction trial: rationale and design.

Authors:  Rosita Zakeri; James A Levine; Gabriel A Koepp; Barry A Borlaug; Julio A Chirinos; Martin LeWinter; Peter VanBuren; Victor G Dávila-Román; Lisa de Las Fuentes; Prateeti Khazanie; Adrian Hernandez; Kevin Anstrom; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2015-01       Impact factor: 8.790

3.  Physical Activity in Cardiac Implantable Electronic Device Recipients During the COVID-19 Pandemic.

Authors:  Abhishek J Deshmukh; Camden Harrell; Jacob Hicks; Ammar M Killu; Siva K Mulpuru; Samuel J Asirvatham; Paul A Friedman; Yong Mei Cha; Malini Madhavan
Journal:  Mayo Clin Proc       Date:  2022-02-02       Impact factor: 11.104

4.  Activity During the COVID-19 Pandemic in Children with Cardiac Rhythm Management Devices.

Authors:  Robert Przybylski; Molly Craig; Matthew Lippmann; Douglas Y Mah; Keri M Shafer; Naomi S Gauthier; Sarah D de Ferranti; John K Triedman; Mark E Alexander
Journal:  Pediatr Cardiol       Date:  2021-12-01       Impact factor: 1.838

Review 5.  Accelerometer-assessed physical behavior and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: A systematic review.

Authors:  Maarten Z H Kolk; Diana M Frodi; Tariq O Andersen; Joss Langford; Soeren Z Diederichsen; Jesper H Svendsen; Hanno L Tan; Reinoud E Knops; Fleur V Y Tjong
Journal:  Cardiovasc Digit Health J       Date:  2021-11-24

Review 6.  Cardiac resynchronization therapy in heart failure patients with atrial fibrillation.

Authors:  Maurizio Gasparini; François Regoli; Paola Galimberti; Carlo Ceriotti; Alessio Cappelleri
Journal:  Europace       Date:  2009-11       Impact factor: 5.214

7.  Measuring Physical Activity With Implanted Cardiac Devices: A Systematic Review.

Authors:  Lindsey Rosman; Rachel Lampert; Samuel F Sears; Matthew M Burg
Journal:  J Am Heart Assoc       Date:  2018-05-17       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.